18:59:44 EDT Thu 28 Mar 2024
Enter Symbol
or Name
USA
CA



ImmunoVaccine Inc
Symbol IMV
Shares Issued 91,722,677
Close 2014-11-21 C$ 0.66
Market Cap C$ 60,536,967
Recent Sedar Documents

ImmunoVaccine begins TSX trading Nov. 26

2014-11-24 17:34 ET - News Release

Dr. Marc Mansour reports

IMMUNOVACCINE RECEIVES FINAL APPROVAL TO GRADUATE TO TSX

ImmunoVaccine Inc. has received final approval from Toronto Stock Exchange (TSX) to graduate from TSX Venture Exchange and list its common shares on the TSX.

The common shares will commence trading on the TSX effective as of the opening of markets on Nov. 26, 2014. Upon listing on the TSX, the common shares will continue to trade under the symbol IMV. In conjunction with the listing of the common shares on TSX, the common shares will be delisted from TSX Venture Exchange upon commencement of trading on TSX on Nov. 26, 2014.

"We look forward to begin trading on TSX and the broader exposure that this exchange will provide ImmunoVaccine to investors in Canada and other key markets," stated Dr. Marc Mansour, chief executive officer of ImmunoVaccine. "With this TSX graduation and our significant cash reserves, which provide operating capital well into 2016, we find ourselves in a strong position to deliver scientifically and financially on our projects."

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.